Your search returned 19 results.

Results
	1.	The proconvulsive activity of quinolone antibiotics in an animal model. [electronic resource] by Williams, P D Helton, D R Producer: 19911018 In: Toxicology letters vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Alterations of in-vitro 5-HT receptor pharmacology as a function of multiple treatment with 5-hydroxytryptamine or 8-hydroxy-2-(di-N-propylamino) tetralin in rat isolated aorta, uterus and fundus, and guinea-pig isolated trachea. [electronic resource] by Helton, D R Colbert, W E Producer: 19950421 In: The Journal of pharmacy and pharmacology vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response. [electronic resource] by Rasmussen, K Kallman, M J Helton, D R Producer: 19971021 In: Synapse (New York, N.Y.) vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Behavioral characterization of the new potent nonselective dopamine agonist pergolide. [electronic resource] by Helton, D R Modlin, D L Williams, P D Producer: 19921120 In: Arzneimittel-Forschung vol. 42 Availability: No items available. Save to lists Add to cart (remove)
	5.	The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response. [electronic resource] by Rasmussen, K Helton, D R Berger, J E Scearce, E Producer: 19940615 In: Annals of the New York Academy of Sciences vol. 713 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. [electronic resource] by Rasmussen, K Helton, D R Berger, J E Scearce, E Producer: 19940331 In: Neuroreport vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity. [electronic resource] by Helton, D R Modlin, D L Tizzano, J P Rasmussen, K Producer: 19950316 In: Psychopharmacology vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle. [electronic resource] by Rasmussen, K Czachura, J F Kallman, M J Helton, D R Producer: 19961211 In: Neuroreport vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Central nervous system characterization of the new cholecystokininB antagonist LY288513. [electronic resource] by Helton, D R Berger, J E Czachura, J F Rasmussen, K Kallman, M J Producer: 19970115 In: Pharmacology, biochemistry, and behavior vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone. [electronic resource] by Helton, D R Osborne, D W Pierson, S K Buonarati, M H Bethem, R A Producer: 20000908 In: Drug metabolism and disposition: the biological fate of chemicals vol. 28 Availability: No items available. Save to lists Add to cart (remove)
	11.	LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. [electronic resource] by Helton, D R Tizzano, J P Monn, J A Schoepp, D D Kallman, M J Producer: 19980505 In: Neuropharmacology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. [electronic resource] by Helton, D R Tizzano, J P Monn, J A Schoepp, D D Kallman, M J Producer: 19980305 In: The Journal of pharmacology and experimental therapeutics vol. 284 Availability: No items available. Save to lists Add to cart (remove)
	13.	General pharmacology of insulin lispro in animals. [electronic resource] by Helton, D R Zimmermann, J L Heim, A Jones, T W Turk, J A Kallman, M J Producer: 19970218 In: Arzneimittel-Forschung vol. 46 Availability: No items available. Save to lists Add to cart (remove)
	14.	Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists. [electronic resource] by Tizzano, J P Griffey, K I Johnson, J A Fix, A S Helton, D R Schoepp, D D Producer: 19940404 In: Neuroscience letters vol. 162 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	General pharmacology of a new potent 5-hydroxytryptamine antagonist. [electronic resource] by Williams, P D Calligaro, D O Colbert, W E Helton, D R Shetler, T Turk, J A Jordan, W H Producer: 19910911 In: Arzneimittel-Forschung vol. 41 Availability: No items available. Save to lists Add to cart (remove)
	16.	The broad-spectrum antiemetic effects ETI-385 result from stimulation of 5-HT1A and 5-HT1D receptors. [electronic resource] by Lucot, J B Brame, R E L Garrett, T L Pfadenhauer, E H Kumar, A Fick, D B Helton, D R Producer: 20150406 In: Experimental brain research vol. 232 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. [electronic resource] by Ornstein, P L Bleisch, T J Arnold, M B Kennedy, J H Wright, R A Johnson, B G Tizzano, J P Helton, D R Kallman, M J Schoepp, D D Hérin, M Producer: 19980227 In: Journal of medicinal chemistry vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. [electronic resource] by Iyengar, S Hipskind, P A Gehlert, D R Schober, D Lobb, K L Nixon, J A Helton, D R Kallman, M J Boucher, S Couture, R Li, D L Simmons, R M Producer: 19970317 In: The Journal of pharmacology and experimental therapeutics vol. 280 Availability: No items available. Save to lists Add to cart (remove)
	19.	Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. [electronic resource] by Monn, J A Valli, M J Massey, S M Wright, R A Salhoff, C R Johnson, B G Howe, T Alt, C A Rhodes, G A Robey, R L Griffey, K R Tizzano, J P Kallman, M J Helton, D R Schoepp, D D Producer: 19970326 In: Journal of medicinal chemistry vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)